Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ventas, Inc. (NYSE: VTR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a healthcare-focused S&P 500 real estate investment trust. Through these filings, investors can review how Ventas reports on its portfolio of approximately 1,400 properties in North America and the United Kingdom, including senior housing communities, outpatient medical buildings, research centers and other healthcare facilities.
Current and historical Forms 8-K offer detailed information about material events affecting Ventas and its subsidiaries. Recent 8-K filings describe items such as the pricing and issuance of senior notes by Ventas Realty, Limited Partnership, amendments to unsecured term loan facilities guaranteed by Ventas, and announcements of quarterly results. These documents help readers understand the company’s capital structure, borrowing arrangements and operating performance disclosures.
Other SEC filings, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, provide broader context on Ventas’s business, risk factors, REIT structure and segment performance. For a healthcare REIT like Ventas, these reports typically include discussions of its senior housing operating portfolio, outpatient medical and research assets, and the demographic and regulatory environment relevant to its properties.
Investors can also use SEC filings to track matters such as dividend practices, debt covenants, and the terms of public offerings or credit agreements. On Stock Titan, AI-powered tools summarize lengthy filings, highlight key sections and surface important changes across reporting periods, helping users interpret complex documents more efficiently. Real-time updates from the SEC’s EDGAR system mean that new Ventas filings, including 10-K, 10-Q, 8-K and related exhibits, are available promptly, while Form 4 and other ownership reports can be consulted to analyze insider transactions and equity-based compensation activity associated with VTR.
Ventas, Inc. director Sumit Roy reported automatic acquisitions of common stock units linked to dividends. On January 15, 2026, he received 48.195 common stock units under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan and 68.063 units under the Non-Employee Directors' Equity Award Deferral Program, both credited as dividend equivalents on Ventas' common stock. Each grant used a reference price of $76.92 per share. After these transactions, Roy directly beneficially owned 21,859.714 shares of Ventas common stock in total.
Ventas, Inc. director Joe Vasquez Rodriguez Jr. reported an automatic grant linked to dividends rather than an open-market trade. On January 15, 2026, he acquired 42.037 units of common stock under the Ventas Non-Employee Directors' Equity Award Deferral Program, tied to dividend equivalents on the company’s common stock. The filing notes a reference price of $76.92 per share, which reflects the closing price on the grant date. After this transaction, Rodriguez beneficially owns 7,806.498 shares of Ventas common stock in direct form. The units are payable solely in common stock and remain subject to his deferral election and the terms of the program.
Ventas, Inc. director Marguerite M. Nader reported an automatic acquisition of common stock units under the company’s Non-Employee Directors' Equity Award Deferral Program. On January 15, 2026, she received 68.063 common stock units at a value based on the $76.92 closing price of Ventas common stock on the grant date, reflecting dividend equivalents on the company’s common stock dividend paid that day.
After this transaction, Nader beneficially owned 21,358.216 shares of Ventas common stock in direct form. The units are payable solely in common stock and remain subject to the terms of her deferral election and the Program, which was adopted under the Ventas, Inc. 2022 Incentive Plan.
Ventas, Inc. director Matthew J. Lustig reported routine share accruals tied to board compensation programs. On January 15, 2026, he acquired 231.163 shares of Ventas common stock at $76.92 per share through units granted under the company’s Non-Employee Directors' Cash Compensation Deferral Plan as dividend equivalents on the common stock dividend paid that day.
On the same date, he acquired an additional 68.063 shares at $76.92 per share through units credited under the Non-Employee Directors' Equity Award Deferral Program, also as dividend equivalents on the January 15 dividend. After these transactions, Lustig directly beneficially owned 92,266.446 shares of Ventas common stock, with all units payable solely in stock under the terms of his deferral elections and the applicable plans.
Ventas, Inc. director Roxanne M. Martino acquired 187.938 common stock units on January 15, 2026 through the company’s Non-Employee Directors' Cash Compensation Deferral Plan. These units were credited as dividend equivalents tied to a cash dividend paid on that date and are payable solely in common stock under the terms of her deferral election and the plan. The filing reports a reference closing price of $76.92 per share as of the grant date, and shows that she beneficially owned a total of 63,267.777 shares of common stock in direct ownership following this transaction.
Ventas, Inc. director Michael J. Embler reported a small stock-based award related to his board service. On January 15, 2026, he acquired 68.063 shares of common stock at a reference price of $76.92 per share. The award came as units under Ventas' Non-Employee Directors' Equity Award Deferral Program, credited as dividend equivalents on the company’s common stock and payable solely in shares. After this grant, Embler directly beneficially owned 14,588.216 shares of Ventas common stock.
Ventas, Inc. director Melody C. Barnes reported a small stock unit accrual under a director equity program. On January 15, 2026, she acquired 68.063 units of common stock, coded as an acquisition, at a reference price of $76.92 per share, which reflects the closing market price on the grant date. The units were credited as dividend equivalents under the Ventas Non-Employee Directors' Equity Award Deferral Program adopted pursuant to the 2022 Incentive Plan and are payable solely in common stock. Following this transaction, she directly beneficially owned 33,193.216 shares of Ventas common stock in total.
Ventas, Inc. amended its main credit agreement on January 7, 2026 through its subsidiary Ventas Realty, Limited Partnership. The change increases the company’s existing unsecured term loan facility from $500 million to $700 million and adds a new unsecured delayed draw term loan facility with a principal amount of $550 million.
After this amendment, total borrowing capacity under the credit agreement can be raised, at the borrower’s option, to $1.75 billion, subject to conditions and additional lender commitments. The company plans to use the increased term loan proceeds to repay in full all outstanding debt under a separate 2023 Credit and Guaranty Agreement, which, along with the related company guarantee, will be terminated once that repayment is completed.
Ventas, Inc. director reports acquisition of deferred stock units
A Ventas, Inc. director reported receiving 484.935 common shares on 01/02/2026 under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. These units were granted in lieu of cash director fees, based on a closing share price of $77.33 on the grant date and are payable solely in common stock under the terms of the director’s deferral election and the plan. Following this transaction, the director beneficially owned a total of 27,966.806 shares of Ventas common stock in direct ownership.
Ventas, Inc. director reports routine equity compensation. A director of Ventas, Inc. (VTR) reported receiving 404.112 shares of common stock, in the form of stock units granted under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. These units were issued on 01/02/2026 in lieu of cash director fees, at a value based on the $77.33 closing price of Ventas common stock on the grant date. After this grant, the director beneficially owns 21,743.456 shares of Ventas common stock, held directly.